ATI RN
Cardiovascular Test Bank Questions
Question 1 of 5
In any acute cardiovascular problem, the essential goal is to
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 2 of 5
In preparing George Gates for a cardiac catheterization, you would
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 3 of 5
The client is on hydrochlorothiazide and digoxin. What effect can the nurse expect?
Correct Answer: C
Rationale: Step-by-step rationale: 1. Hydrochlorothiazide is a diuretic that can cause hypokalemia. 2. Digoxin toxicity is more likely with low potassium levels. 3. Therefore, hydrochlorothiazide decreasing potassium levels can increase the risk of digoxin toxicity. Summary: A: Incorrect. Hydrochlorothiazide does not increase digoxin levels. B: Incorrect. Hydrochlorothiazide does not decrease digoxin levels. C: Correct. Hydrochlorothiazide can decrease potassium, increasing digoxin toxicity risk. D: Incorrect. Digoxin does not increase the effectiveness of hydrochlorothiazide.
Question 4 of 5
The client is on a cardio-selective beta blocker. Why might this be ordered?
Correct Answer: C
Rationale: The correct answer is C because a client with asthma would be at risk of bronchoconstriction if given a non-cardio-selective beta blocker. Cardio-selective beta blockers primarily target beta-1 receptors in the heart, sparing beta-2 receptors in the lungs. This reduces the risk of bronchoconstriction in clients with asthma. Choices A, B, and D are incorrect because they do not address the specific concern of bronchoconstriction in clients with asthma. Answer A refers to blood vessel blockage, which is not the primary concern in this scenario. Answer B mentions hypotension, which is not directly related to the risk of bronchoconstriction in asthma. Answer D discusses hypoglycemia, which is not a primary concern with beta blockers in asthma management.
Question 5 of 5
The client is taking a class IB anti-arrhythmic drug. What drug might that be?
Correct Answer: B
Rationale: The correct answer is B: Procainamide. Class IB anti-arrhythmic drugs, such as Procainamide, work by blocking sodium channels, leading to a decrease in conduction velocity and an increase in action potential duration. Lidocaine (choice A) is a Class IB drug but is primarily used for acute ventricular arrhythmias. Mexiletine (choice C) is a similar drug to Lidocaine but is not commonly used. Metoprolol (choice D) is a beta-blocker and belongs to a different class of anti-arrhythmic drugs. Hence, Procainamide is the most fitting choice among the options provided.